Mount Sinai Ventures

Mount Sinai Ventures is the strategic investment arm of the Mount Sinai Health System in New York City, backing digital health innovations that can be validated within its clinical network. As a corporate venture capital entity attached to a large academic medical center, it carries the dual mandate of financial return and strategic alignment with the parent system’s clinical and research priorities. The fund’s focus areas include digital health and care delivery or tech-enabled services. AI focus is not formally indicated, but AI-enabled clinical tools that solve operational or care-quality problems within Mount Sinai are a natural fit.

The team invests at seed and Series A stages with check sizes between $1M and $5M. Investments are concentrated in the United States and typically anchored to companies that can run validation, pilot, or research collaborations inside the Mount Sinai system. The fund commonly co-invests with traditional venture firms and other strategic health system investors, providing clinical credibility rather than leading large rounds.

Founders should approach with a clear plan for how their product can be tested and adopted inside an academic medical center, including governance, IRB, and integration considerations. AI tools that align with established Mount Sinai service lines or research strengths will be received more favorably. Introductions through Mount Sinai clinicians, department leadership, or existing portfolio company founders are the most credible inbound paths into the venture team.